Dr Mas Ayu is an Epidemiologist in the Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya. She is also a consultant epidemiologist at the University Malaya Medical Centre. Her research interest focuses on mental health, substance abuse and psychopharmacology, especially the side effect of metabolic syndrome due to the treatment of schizophrenia. A recipient of several research grants, she has many collaborative research activities with University Malaya Centre of Addiction Sciences. Her recent project is Enhancing Quality and Longevity of Life of Malaysian B40 under Long Term Research Grant Scheme (LRGS). She also involved in another project for B40 - Coping to Live with COVID-19: The New Norm which was funded by WHO.   As a public health specialist in infectious disease and field epidemiologist, Dr Mas Ayu is the member of Malaysia One Health University Network (MyOHUN) which is part of USAID. She is active in activity related to One Health in Malaysia and Southeast Asia Region. Dr Mas Ayu also has research interest on communicable diseases mainly focusing on vector borne diseases like Chikungunya and Dengue Fever. She has research collaboration through Malaysia-Sweden Research Link with Umea University, working on the early warning system of dengue outbreak. Dr Mas Ayu attended the evidence-based medicine (EBM) practice workshop as training for trainer in Oxford University in 2008, funded by grants from the European Union. The international collaboration was together with Utrecht (UMCU), Centre for Evidence-Based Medicine (CEBM), University of Oxford, the Rumah Sakit Cipto Mangunkusumo (RSCM) Hospital, Jakarta and University of Malaya. She has conducted several EBM workshops together with other trainers. She also served as panel for The Malaysian Qualifications Agency (MQA), which is a statutory body in Malaysia to accredit academic programs provided by educational institutions providing post-secondary or higher education and facilitate the accreditation and articulation of qualifications.

Dr. Syakirah Rifa’in@Mohd Rifain is a Senior Lecturer for Department of Arabic and Middle Eastern Languages at the Faculty of Languages and Linguistics, UM. She graduated from Islamic Science University of Malaysia in Arabic Language and Communication Studies. She obtained her Master in Modern Language Studies in Arabic Language, Universiti Malaya. She completed her PhD in Arabic Language at Faculty of Languages and Linguistics, UM. Her research interest area includes Balaghah, Pragmatic and Semantic. Currently, she is involved in research related to Arabic for Specific Purpose in University Malaya.

I obtained my BSc and PhD in Pharmacology from the University of Dundee (UK), joined the University of Malaya as a tutor in 1979, and was promoted to Professor of Pharmacology in 2000. I was the Head of the Department of Pharmacology for over 18 years from 1994, which ended in August 2014, following my appointment into the university's Board of Directors (BOD). My appointment as member of BOD ended in Dec 2015. My main research currently is in pharmacogenomics (PGx), being the country representative on PGx research for an international group (Global Genomic Medicine Collaborative under the National Institute of Health, USA) and 2 regional groups (including the Southeast Asian Pharmacogenomics Network). PGx is currently one of the fastest growing research area globally and I have supervised over 25 postgraduate students in this field over the years. My laboratory was awarded research funding of over RM3.5 million over a period of 5 years from 2011 to 2015, and our team has published over 105 papers since then. I have been invited to speak on PGx at international and national conferences.  I am also a member of at least 7 committees at the national level, the most significant being the National Committee for Clinical Research (NCCR), chaired by the Director-General of Health, Malaysia. My expertise in Good Clinical Practice (GCP) is recognised, being invited to be a speaker and facilitator at GCP Workshops throughout the country. My expertise also extends to being a consultant for contract research in the form of Bioequivalence (BE) Studies for various generic drug manufacturers since 1999, and to date, we have completed over 32 consultancies.  My Bioequivalence Centre has two accreditations, one under SAMM ISO-IEC 17025/2001, and the other is under Ministry of Health, and is one of only four accredited centres in Malaysia. I was appointed by the Minister of Science, Technology and Innovations, to be a member of the National Bioethics Council (NBC) and presented the Keynote Address at its launch. I have been a Vice-Chairman of NBC. I was also appointed by the Deputy Prime Minister (who was also then the Minister of Education), to be a representive of the University's Senate to the University's Board of Directors, the appointment ended in Dec 2015.  I am also an active member of several NGOs, and frequently and passionately participate in various community and student events.